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Abstract The binaphthyl derivative cladosporol 3 was
supplied from 60 to 200 mg l−1 to shaken cultures of
Cladosporium cf. cladosporioides. Compared to blank, fun-
gal biomass was not affected by adding cladosporol till
100 mg l−1: it rather increased at higher ratios between 150
and 200 mg l−1. The production of the major pentacyclic
metabolite 1, a cytokine production and tyrosine kinase
inhibitor, was enhanced tenfold when cladosporol was
supplied at the highest ratio (200 mg l−1) to shaken grow-
ing cultures of the fungus. The bioconversion of clado-
sporol to cladosporol D through reductive cleavage of the
epoxide group was also observed. Interest in this kind of
metabolites lies in their potential activity vs DNA topo-
isomerase I.
Introduction
In a model of antitumor strategy, novel chemotherapeutics
are represented by inhibitors of topoisomerases, a class of
nuclear enzymes involved in transcription and information
processing by catalyzing topological change in DNA struc-
ture (Liu 1994).
Among these antitumor drugs, several small molecules
with specific cell activity and reduced side effects are now
progressing to clinical trials. Nevertheless, the large num-
ber of cancer types still demands new compounds to be
tested in the wide range of assays designed to unravel
the biochemical mechanisms aberrantly activated in the
different tumor cells.
A series of pentacyclic compounds, including the major
metabolite 1 with cytokine production and tyrosine kinase
inhibitory properties, has been recently isolated from cul-
tures of Cladosporium cf. cladosporioides (Wrigley et al.
2001). These metabolites are novel reduced benzo[j]flu-
oranthen-ones, related in some aspects to bulgarein 2 and
bulgarhodin, the first of which induces mammalian topo-
isomerase I-mediated DNA cleavage in vitro (Edwards and
Lockett 1976; Fujii et al. 1993). In a screening program
devoted to find new promising topoisomerase I inhibitor
compounds, we investigated the possibility of biotrans-
forming the binaphthyl derivative cladosporol 3 (Sakagami
et al. 1995), by supplying it to the culture of C. clad-
osporioides. This paper reports both the production en-
hancement of 1 by supplying cladosporol 3 to shake
cultures of C. cladosporioides and the accompanying bio-
transformation of cladosporol 3 to cladosporol D 4 (see
Scheme 1).
Materials and methods
Cladosporium cf. cladosporioides was kindly received as
monocytogenetic strain Culture CollectionN° CBUK20700
from Cubist (formerly TerraGen and Xenova).
The master fungal strain was preserved as mycelium
plugs maintained in 10% aqueous glycerol at 4°C. Stock
cultures were grown at 24°C on potato dextrose agar.
After preliminary screening on several media either in
surface or submerged culture, C. cladosporioides large-
scale cultures were made in Roux flasks (750 ml) con-
taining 100 ml SSA (sucrose, soybean flour, KH2PO4,
MgSO4·7 H2O, Mg3(PO4)2·8 H2O, agar at 50, 15, 0.5, 0.5,
0.5, 20 g l−1, respectively). Flasks were inoculated with
5 ml of a shaken 4-day preculture in MYG broth (malt
extract, yeast extract, glucose at 20, 2, 20 g l−1, re-
spectively), maintained at 24°C in the dark and extracted
twice with AcOEt/MeOH (100:1) after 14-day growth. The
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organic fraction was dried with Na2SO4 and evaporated in
a Rotavapor.
Broth cultures were made in baffled Erlenmeyer flasks
(300 ml) containing 100 ml CSB (corn steep, glucose,
NaNO3, K2HPO4, KH2PO4, MgSO4·7 H2O, KCl, FeSO4·7
H2O at 10, 30, 2, 1, 0.5, 0.5, 0.5, 0.02 g l
−1, respectively,
plus 0.1% antifoam A), inoculated as previously described
and placed on a rotary shaker at 180 rpm (24°C, dark).
They served for verifying biotransformation of cladosporol
3. This compound was purified from crude extracts of
Cladosporium tenuissimum ITT21, cultured as already
described (Nasini et al. 2004). It was dissolved in DMSO
and supplied at 6, 10, 15 and 20 mg/flask to C. clad-
osporioides cultures after 4 days from inoculation. Solvent
did not exceed 0.1% (v/v). Each cladosporol concentra-
tion was tested twice on 20 shake flasks. Controls were
inoculated flasks containing only solvent or uninoculated
flasks containing cladosporol. Production of metabolites
and conversion of cladosporol 3 were monitored every
24 h on withdrawn samples (10 ml) by extraction and
chromatography, as described below. Cultures were har-
vested and extracted around 96 h after cladosporol ad-
dition, when it had disappeared completely and production
of 1 reached its maximum. Mycelia were separated from
culture broth by centrifugation (3,500×g for 15 min), dried
in an oven under vacuum at 40°C, and both separately
extracted twice with AcOEt/MeOH (100:1). The organic
solvents were evaporated in a Rotavapor. The crude ex-
tracts were checked for metabolite production by means of
thin-layer chromatography (TLC) on Silica gel plates in
CH2Cl2/MeOH 15:1 with pure samples as references.
Separation and purification of the metabolites were
performed on silica gel (0.04–0.06 mm) by column chro-
matography with a stepwise elution with CH2Cl2:MeOH
from 200:1 to 4:1. Further purification was performed
on preparative plates (PLC) with CH2Cl2:MeOH (15:1)
as eluent.
The purified compounds were checked for their identity
by NMR, MS, and consistency with other spectroscopic
data reported for reference compounds (Nasini et al. 2004;
Wrigley et al. 2001).
Results
The pentacyclic active metabolite 1 has been demonstrated
to be a tyrosine kinase inhibitor (Wrigley et al. 2001). In
several agar and liquid media tested, C. cladosporioides
was able to form high biomass and sporulate, but the
amount of this metabolite and related compounds occurred
in a low amount in CSB (6 mg l−1) and was only just
detected in SSA, having the same composition previously
utilized for bulgarein production by Heteroconium sp. in a
jar fermenter (Fujii et al. 1993), plus agar. Its appreciable
de novo production in surface culture is here first report-
ed: the highest yield of 1 was obtained at the end of ex-
ponential growth phase (40 mg l−1, corresponding to ten
Roux flasks).
Bulgarein 2 was shown to induce mammalian topo-
isomerase I−mediated DNA cleavage in vitro with activity
comparable to that of camptothecin, but with a different
mechanism of stabilizing this reversible enzyme−DNA
cleavable complex (Fujii et al. 1993), and thus far, rep-
resenting a new class of potentially active agents. Un-
fortunately the natural occurrence of 2 is restricted to
the winter fruit bodies of the wood decay ascomycete
Bulgaria inquinans, because batch cultures of the pro-
ducing fungi, B. inquinans, and Heteroconium sp., the
latter received from Kiowa Ltd. (Fujii et al. 1993), were
unsuccessful in producing the desired metabolite.
Cladosporol 3 is a known 1,3-β-glucan inhibitor pro-
duced by several Cladosporium strains (Sakagami et al.
1995; Moricca et al. 2001). Considerable amount of 3 was
produced by C. tenuissimum, hyperparasite of rust path-
ogens, together with a family of related antifungal com-
pounds, partly responsible for the mycoparasitic properties
of the producing strain (Assante et al. 2004): from batch
cultures more than 200 mg l−1 could be typically collected.
Its structural relation to metabolites 1, 2, and other active
perylenequinone compounds led us to perform biotrans-
formation trials using C. cladosporioides as a microbial
regiospecific biocatalyst. It was supplied as a cosubstrate
at varying amounts from 6 to 20 mg-flask to growing C.
cladosporioides in CSB medium. The compound, added
from 0 to 100 mg l−1, did not inhibit the growth of the
Scheme 1 Structures of the Bynaphthyl compound 1, Bulgarein 2,
Cladosporol 3 and Cladosporol D 4
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fungus, the biomass production reaching an average of
the final cell dry weight (CDW) of 10.2±1.1 g l−1 after
96 h, and still increasing slowly at highest ratio of sup-
ply. Metabolite 1 production was monitored daily and
reached its maximum 96 h after cladosporol supply. Lon-
ger cultivation periods were inadequate because fungal
mycelium underwent lysis. At this time of the process, the
total yield of 1 increased from 6 mg l−1 with no clad-
osporol added to 72 mg l−1 with 200 mg l−1 cladosporol
added. Cladosporol 3 at 6% increased the total amount
of metabolite 1 by about 50% compared to blank. When
supplied from 10 to 15%, production of 1 underwent a
sudden increase and was enhanced ten times with respect
to controls, whereas at the highest concentration of 20%,
production of 1 was increased further. No cladosporol
was recovered at the end of all experiments, its consump-
tion being complete in the same 4-day period. Its exhaus-
tion was accompanied by formation of cladosporol D 4 at
different degrees. This bioconversion occurred at 5%,
when 3 was added at the lowest amount (60 mg l−1), re-
mained around 10% at 3 supplied from 100 to 150 mg l−1,
and reached the 20% when 3 was supplied at the highest
concentration tested (200 mg l−1). Noninoculated medi-
um supplemented with cladosporol 3 served as chemical
blanks where no conversion or degradation could be re-
corded over the whole period. Results are summarized
in Fig. 1. Whereas cladosporol D 4 was always and only
recovered from broth, metabolite 1 was extracted either
from broth (approximately 60%) and frommycelium (40%)
at every cladosporol 3 concentration used.
Discussion
Binaphthyl systems, occurring in cladosporol 3, are also
produced by many fungal species, i.e., Daldinia spp. and
other xylariaceaus taxa, via the poliketide pathway. An
intramolecular phenol oxidation results in the formation
of polyaromatic metabolites. One of the simplest natu-
ral compounds, the 4,9−dihydroxyperylene−3,10−quinone,
shows a coupling between C1 and C5′ (for enumeration,
see skeleton of 3 Scheme 1), and is considered the parent
compound of several bioactive-extended quinone pig-
ments, like cercosporins, phleichromes, elsinochromes, cal-
phostins, and cladochromes (Weiss et al. 1987; Arnone
et al. 1989). The biological activity of the aforementioned
compounds is mainly due to their photodynamic proper-
ties, which in the cladochromes and calphostins have been
also related to their capability to inhibit the protein kinase C
isoenzyme family (Tamaoki and Nakano 1990). Inasmuch
as a modified skeleton of the binaphthyl system occurs
also in the derivative 1, in bulgarein 2 and bulgarhodin
(Edwards and Lockett 1976), and in other few compounds,
i.e., hypoxylonols (Koyama et al. 2002), hortein (Brauers
et al. 2001), and daldinones (Quang et al. 2002), it is rea-
sonable to assume that their formation occurs by a para–
meta coupling between C1 and C3′ in the two aromatic
diphenyl rings.
The bioconversion of cladosporol 3 to cladosporol D
4 involves the reductive cleavage of the epoxide, albeit
at low rate, possibly catalyzed by xenobiotic−induced
unspecific catabolic hydrolases and is a quite common
biotransformation finalized to detoxify a xenobiotic. The
enhancement of the production of compound 1 by C.
cladosporioides could be seen as an accumulation of a
dead-end product or a defence substance, as a result of
the fungus–cladosporol interactions. However, the bio-
chemical pathway should be investigated further, even-
tually feeding the fungus with 13C-cladosporol or other
binaphthyl derivatives to clarify the biosynthetic steps
involved. New research will also consider the possibility
of introducing some structural chemical modifications
in metabolite 1, i.e., by oxidation or dehydrogenation
reactions, to obtain new derivatives to test for biological
activity.
Fig. 1 Enhancement of com-
pound 1 by adding cladosporol
3 and biotransformation of 3 to
4 by C. cladosporioides (CDW
cell dry weight). 146×99 mm
(300×300 DPI)
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